-
Feb 24, 2026 23:59 UTC
other_material
materiality 0.85
neutral
item 5.01item 5.03item 7.1item 8.1
Bio-Path issues Series S preferred to CEO entity, giving 51% voting control; cancels reverse split, plans trial restarts
Issued 51 Series S preferred shares (1% vote each) and 2M warrants to CEO-controlled SGA, granting 51% voting control.
-
Nov 14, 2025 23:59 UTC
other
materiality 0.70
negative
item 5.02item 8.01
Bio-Path warns of going concern doubt, seeks financing; director resigns
Director Douglas Morris resigned effective Nov 13, 2025; resignation received Nov 4.
-
Oct 29, 2025 23:59 UTC
leadership
materiality 0.60
neutral
item 5.02
Bio-Path appoints Vikram Grover as CEO, CFO and director; Morris resigns as interim CEO/CFO
Vikram Grover elected President, CEO, CFO and Board member effective October 22, 2025.
-
Aug 13, 2025 23:59 UTC
other_material
materiality 0.65
negative
item 4.01item 9.01
Bio-Path Holdings dismisses EY as auditor; no disagreements; seeking replacement
Board approved dismissal of EY as independent auditor on Aug 13, 2025, effective immediately.
-
Jun 24, 2025 23:59 UTC
other_material
materiality 0.95
negative
item 5.02item 8.01
Bio-Path Holdings CEO and entire board resign; operations paused, employees furloughed
CEO/President/CFO/Chairman Peter H. Nielsen resigned June 20, 2025, from all roles.